BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 26227855)

  • 1. APOBEC3G governs to ensure cellular oncogenic transformation.
    Garg A; Kaul D; Chauhan N
    Blood Cells Mol Dis; 2015 Oct; 55(3):248-54. PubMed ID: 26227855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOBEC3G governs the generation of truncated AATF protein to ensure oncogenic transformation.
    Sharma S; Garg A; Dhanda RS; Kaul D
    Cell Biol Int; 2016 Dec; 40(12):1366-1371. PubMed ID: 27611213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic programmes cellular genomic-immunity through miR-2909 RNomics.
    Kaul D; Sharma S; Sharma M; Arora M; Arora M
    Gene; 2014 Feb; 536(2):326-31. PubMed ID: 24361962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MALT1 induced immune response is governed by miR-2909 RNomics.
    Kaul D; Arora M; Garg A; Sharma S
    Mol Immunol; 2015 Mar; 64(1):210-7. PubMed ID: 25500259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enhanced protein production of Vif and APOBEC3G by HIV-1 Vpr].
    Li L; Liang D; Li JY; Zhao YQ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Feb; 22(1):39-41. PubMed ID: 18414697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1].
    Fan B; Cen S; Jiang JD
    Yao Xue Xue Bao; 2008 Jul; 43(7):678-82. PubMed ID: 18819469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and real-time monitoring of the enzymatic reaction of APOBEC3G which is involved in anti-HIV activity.
    Furukawa A; Nagata T; Matsugami A; Habu Y; Sugiyama R; Hayashi F; Kobayashi N; Yokoyama S; Takaku H; Katahira M
    Nucleic Acids Symp Ser (Oxf); 2009; (53):87-8. PubMed ID: 19749273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOBEC3G & HTLV-1: inhibition without deamination.
    Strebel K
    Retrovirology; 2005 May; 2():37. PubMed ID: 15921532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of APOBEC3G in kidney cells.
    Komohara Y; Suekane S; Noguchi M; Matsuoka K; Yamada A; Itoh K
    Tissue Antigens; 2007 Jan; 69(1):95-8. PubMed ID: 17212712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory effect of apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and its family members on the activity of cellular microRNAs.
    Zhang H
    Prog Mol Subcell Biol; 2010; 50():71-83. PubMed ID: 19841882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells.
    Kao S; Miyagi E; Khan MA; Takeuchi H; Opi S; Goila-Gaur R; Strebel K
    Retrovirology; 2004 Sep; 1():27. PubMed ID: 15373943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis.
    Ding Q; Chang CJ; Xie X; Xia W; Yang JY; Wang SC; Wang Y; Xia J; Chen L; Cai C; Li H; Yen CJ; Kuo HP; Lee DF; Lang J; Huo L; Cheng X; Chen YJ; Li CW; Jeng LB; Hsu JL; Li LY; Tan A; Curley SA; Ellis LM; Dubois RN; Hung MC
    J Clin Invest; 2011 Nov; 121(11):4526-36. PubMed ID: 21985787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Vif protein blocks the cytidine deaminase activity of B-cell specific AID in E. coli by a similar mechanism of action.
    Santa-Marta M; Aires da Silva F; Fonseca AM; Rato S; Goncalves J
    Mol Immunol; 2007 Jan; 44(4):583-90. PubMed ID: 16580072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOBEC3G expression is restricted to neurons in the brains of pigtailed macaques.
    Hill MS; Mulcahy ER; Gomez ML; Pacyniak E; Berman NE; Stephens EB
    AIDS Res Hum Retroviruses; 2006 Jun; 22(6):541-50. PubMed ID: 16796529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase.
    Suspène R; Sommer P; Henry M; Ferris S; Guétard D; Pochet S; Chester A; Navaratnam N; Wain-Hobson S; Vartanian JP
    Nucleic Acids Res; 2004; 32(8):2421-9. PubMed ID: 15121899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOBEC3G has the ability to programme T cell plasticity.
    Garg A; Kaul D
    Blood Cells Mol Dis; 2016 Jul; 59():108-12. PubMed ID: 27282578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes.
    Tanaka Y; Marusawa H; Seno H; Matsumoto Y; Ueda Y; Kodama Y; Endo Y; Yamauchi J; Matsumoto T; Takaori-Kondo A; Ikai I; Chiba T
    Biochem Biophys Res Commun; 2006 Mar; 341(2):314-9. PubMed ID: 16426578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary function of the two catalytic domains of APOBEC3G.
    Navarro F; Bollman B; Chen H; König R; Yu Q; Chiles K; Landau NR
    Virology; 2005 Mar; 333(2):374-86. PubMed ID: 15721369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOBEC-mediated interference with hepadnavirus production.
    Rösler C; Köck J; Kann M; Malim MH; Blum HE; Baumert TF; von Weizsäcker F
    Hepatology; 2005 Aug; 42(2):301-9. PubMed ID: 16025511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction.
    Schumacher AJ; Haché G; Macduff DA; Brown WL; Harris RS
    J Virol; 2008 Mar; 82(6):2652-60. PubMed ID: 18184715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.